June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Synthetic LXR Agonists Enhances Vasoreparative Function and Proliferation of Bone Marrow-Derived Stem Cells in Diabetic Mouse Models
Author Affiliations & Notes
  • Thao Trinh
    Physiology, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Eleni Beli
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Sugata Hazra
    Geriatrics, University of Utah, Salt Lake, Utah, United States
  • Lynn Shaw
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Yaqian Duan
    Physiology, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Moshe Levi
    Department of Medicine, University of Colorado Denver, Denver, Colorado, United States
  • Julia V Busik
    Physiology, Michigan State University, East Lansing, Michigan, United States
  • Maria B Grant
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Physiology, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Footnotes
    Commercial Relationships   Thao Trinh, None; Eleni Beli, None; Sugata Hazra, None; Lynn Shaw, None; Yaqian Duan, None; Moshe Levi, None; Julia Busik, None; Maria Grant, None
  • Footnotes
    Support  1R01EY025383-01A1
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 218. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Thao Trinh, Eleni Beli, Sugata Hazra, Lynn Shaw, Yaqian Duan, Moshe Levi, Julia V Busik, Maria B Grant; Synthetic LXR Agonists Enhances Vasoreparative Function and Proliferation of Bone Marrow-Derived Stem Cells in Diabetic Mouse Models. Invest. Ophthalmol. Vis. Sci. 2017;58(8):218.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Purpose: Despite advances in pharmacological therapy, diabetic retinopathy (DR) remains the most common cause of visual impairment and blindness among working-age adults. Clinical evidence demonstrates an intriguing association of lipid abnormalities and DR and studies in diabetic rodents reveal prevention of DR via activation of nuclear hormone liver X receptors (LXRα/LXRβ). In this study, we asked whether the synthetic LXR agonists GW3965 or DMHCA can delay the development of DR in part through enhancing the vascular reparative function of circulating angiogenic cells (CACs).

Methods : Methods: db/db mice were given LXR agonists either GW3965 (20 mg/kg) through feeding with chow containing this test agent from 8 weeks of age until 24 weeks of age or DMHCA (80 mg/kg) injected daily for 2 weeks. Eyes were used for enumeration of acellular capillaries and bone marrow was harvested for migration studies and flow cytometry analysis. GW3965 (20 mg/kg) was administered short term (7 days) to diabetic mice via oral gavage, and freshly isolated hematopoietic stem cells were used for proliferation assay at 12 hour and 24 hour.

Results : Results: CACs from db/db mice treated with GW3965 showed significantly greater migration towards hypoxia-regulated factors, CXCL-12 and VEGF (p < 0.05) than CACs from db/db mice on normal chow. In parallel with this result, we observed a significant reduction in the number of acellular capillaries in the retina of db/db mice on GW3965 compared to diabetic mice on normal chow (p<0.05). Interestingly, DMHCA treatment significantly increased overall stem cell populations, specifically the short-term repopulating cells and only a trend increase in long-term repopulating cells. Intriguingly, seven-days of GW3965 significantly increased the proliferation rate of murine hematopoietic stem cells (HSCs) (p < 0.05).

Conclusions : Conclusions: Short-term LXR activation by LXR agonists in diabetic mice significantly enhanced proliferation capacity and the overall HSCs population and long-term administration of LXR agonist in T2DM mice reduced the number of acellular capillaries by favorably influencing the vasoreparative function of circulating CACs.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×